Inventor · disambiguated record
Jane Spetzler
Also filed as: SPETZLER JANE
14 granted patents·15 pending applications·204 citations·filing 2001–2020
93Inventor score
Top patents by PatentIndex Score
29 records- 0196US10005827B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2016·Granted Jun 26, 2018·24 cites·43 claims
- 0295US11117947B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2019·Granted Sep 14, 2021·7 cites·23 claims
- 0394US11034746B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2018·Granted Jun 15, 2021·6 cites·40 claims
- 0491US9067977B2Peptides derivatized with A-B-C-D- and their therapeutical useNOVO NORDISK AS·Filed 2013·Granted Jun 30, 2015·18 cites·22 claims
- 0590US8895694B2Glucagon-Like Peptide-1 derivatives and their pharmaceutical useSPETZLER JANE·Filed 2008·Granted Nov 25, 2014·29 cites·11 claims
- 0690US6875741B2Insulin and IGF-1 receptor agonists and antagonistsFiled 2001·Granted Apr 5, 2005·69 cites·30 claims
- 0787US8815802B2GLP-1 analogues and derivativesKALTHOFF CHRISTOPH·Filed 2010·Granted Aug 26, 2014·19 cites·12 claims
- 0886US9708383B2Double-acylated GLP-1 derivativesMADSEN ALICE RAVN·Filed 2011·Granted Jul 18, 2017·14 cites·16 claims
- 0984US9409966B2Glucagon-like peptide-1 derivatives and their pharmaceutical useNOVO NORDISK AS·Filed 2014·Granted Aug 9, 2016·6 cites·22 claims
- 1079US9012398B2Acylated exendin-4 compoundsLAU JESPER·Filed 2012·Granted Apr 21, 2015·4 cites·18 claims
- 1176US9556250B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 1275US9657079B2Truncated GLP-1 derivatives and their therapeutical useNOVO NORDISK AS·Filed 2014·Granted May 23, 2017·2 cites·14 claims
- 1370US9260503B2Multi-substituted insulinsHOEG-JENSEN THOMAS·Filed 2012·Granted Feb 16, 2016·3 cites·15 claims
- 1468US9988430B2Stable GLP-1 based GLP-1/glucagon receptor co-agonistsNOVO NORDISK AS·Filed 2015·Granted Jun 5, 2018·1 cites·29 claims
- 1565US2009192072A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1661US2007265189A1Insulin and igf-1 receptor agonists and antagonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1758US2011039779A1Igf-1r binding proteins and antagonistsOSTERGAARD SOREN·Filed 2008·Application pending·0 cites
- 1858US2010292133A1Truncated glp-1 derivaties and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1958US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2057US2003236190A1Isulin and IGF-1 receptor agonists and antagonistsFiled 2002·Application pending·0 cites
- 2155US2009318353A1Acylated Exendin-4 CompoundsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2253US2011124556A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2349US2021221867A1Compounds Capable of Binding to Melanocortin 4 ReceptorNOVO NORDISK AS·Filed 2019·Application pending·0 cites
- 2446US2011275559A1Long-Acting Y2 and/or Y4 Receptor AgonistsNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 2544US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 2644US2010016237A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2743US2009062192A1Dimeric Peptide Agonists of the Glp-1 ReceptorNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2840US2009203581A1Novel Peptides for Use in the Treatment of ObesityNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2935US2013012432A1Peptides for Treatment of ObesityNOVO NORDISK AS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jane Spetzler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →